test

Sherman G. Souther

@Vr Adviser, Llc

Latest period2024 - Q3ReportedManaged Assets$1.909BTotal holdings38
Assets growth rate21.59%Assets growth rate (2-Q avg)-1.85%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Vr Adviser, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.

Assets under management

The assets under management (AUM) of Vr Adviser, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.909B in assets, with a quarterly growth rate of 21.59% and a 2-quarter average growth rate of -1.85%. The portfolio is managed by Sherman G. Souther, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APGEApogee Therapeutics Inc
Recent Activity
26.14%
$498.898M
8.493M shares@ $58.75 avg price
OCULOcular Therapeutix Inc
Recent Activity
5.82%
$111.033M
12.762M shares@ $8.7 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
5.39%
$102.832M
4.026M shares@ $25.55 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Increased 0.01%
4.63%
$88.332M
3.883M shares@ $22.76 avg price
APLTApplied Therapeutics Inc
Recent Activity
Increased 2.96%
4.38%
$83.513M
9.825M shares@ $8.5 avg price
SYRESpyre Therapeutics Inc
Recent Activity
4.14%
$78.979M
2.685M shares@ $29.42 avg price
DYNDyne Therapeutics Inc
Recent Activity
4.09%
$78.087M
2.174M shares@ $35.93 avg price
ORKAOruka Therapeutics Inc
Recent Activity
New Position
3.97%
$75.629M
3.086M shares@ $24.51 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
3.8%
$72.372M
6.25M shares@ $11.59 avg price
PHVSPharvaris N V
Recent Activity
3.3%
$62.887M
3.396M shares@ $18.52 avg price